SYSTEMATIC MEDIASTINAL BILATERAL LYMPH DISSECTION IN LUNG CARCINOMA TREATMENT: SURGICAL APPROACH PERFECTION

doi:10.17816/PAVLOVJ20092124-129

I.P. Pavlov Russian Medical Biological Herald ›› 2009, Vol. 17 ›› Issue (2) :124 -129. DOI: 10.17816/PAVLOVJ20092124-129

Articles

other

SYSTEMATIC MEDIASTINAL BILATERAL LYMPH DISSECTION IN LUNG CARCINOMA TREATMENT: SURGICAL APPROACH PERFECTION

Author information +

History +

PDF

Abstract

The systematic lymph dissection, a drastic treatment procedure in the surgical treatment of lung carcinoma, is declared to be an operative procedure helping to assess the true extent of a neoplastic [tumor] process. From the 300 operative interventions the 150 (50,0%) came to expanded operations which were followed by a systematic lymph dissection from principal considerations. The other 150 (50,0%) patients were operated typically without any systematic mediastinal lymph dissection. The general five-year probability of survival (equal to 30%), while the postoperative lethality is equal to 6,7%, speaks for a surgical assistance of a good quality in the clinical hospital. To present day 254 (85,0% from the 300) patients have been watched over.

Cite this article

Download citation ▾

null. SYSTEMATIC MEDIASTINAL BILATERAL LYMPH DISSECTION IN LUNG CARCINOMA TREATMENT: SURGICAL APPROACH PERFECTION. I.P. Pavlov Russian Medical Biological Herald, 2009, 17(2): 124-129 DOI:10.17816/PAVLOVJ20092124-129

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Важенин А.В. Радиационная онкология: организация, тактика, пути развития / А.В. Важенин.- М.: Изд-во РАМН, 2003.- 236 с.

[2]	Давыдов М.И. Принципы хирургического лечения злокачественных опухолей в торако-абдоминальной клинике / М.И. Давыдов // Вопр. онкологии. - 2002. - Т. 48, №4.-5. - С. 468-479.

[3]	Давыдов М.И. Рак легкого / М.И. Давыдов, Б.Е. Полоцкий. - М.: Радикс,1994. -210 с.

[4]	Стилиди И.С. Хирургическое лечение рака легкого / И.С. Стилиди, М.Д. Тер-Ованесов // Практическая онкология. - 2000. - №3. - С.21 - 23.

[5]	Трахтенберг А.X. Рак легкого / А.X. Трахтенберг.- М.,1987. - 303 с.

[6]	Харченко В.П. Рак легкого / В.П. Харченко, Н.В. Кузьмин.- М.: Медицина,1994.- 480 с.

[7]	Preoperative chemotherapy followed by surgery compared with primary surgery in resectablestage I (except T1N0), II and 111A non-small-cell lung cancer / A. De Pierre [et al.] // J. ClinOncol. - 2002. - №20. - P. 247-253.

[8]	Ginsberg R. A non-small-cell lung cancer / R. Ginsberg, E. Vokes, A. Raben // Cancer principles and practice of oncology / eds.: V.Т. DeVita, S. Hellman, S.A. Rosenberg.- Philadelphia: Lippincott, 1997. - P. 858-911.

[9]	Ginsberg R. Role of surgery in the treatment of stage I and II lung cancer / R. Ginsberg // Proc. ASCO. - 2001. - P. 460-464.

[10]	Thorascopic staging of 111 Bnon-small cell lung cancer before neoadjuvant therapy / Т. De Giacomo [et al.] // Ann ThoracSurg.-1997.-Vol. 64, №5.-P.1409.

[11]	Pistrers K. Stage I/I I non-small-cell lung cancer: Is there a role forcombined-modality therapy? / K. Pistrers // Proc. ASCO. - 2002. - P. 465-470.

[12]	PORT Meta-analysis Trialists Group. Postoperative radiotherapy innon-small-cell lung cancer: systematic review and meta-analysis ofindividual patient data from nine controlled trials // Lancet. -1998. - Vol. 352. - P. 257-263.

[13]	Mediastinoscopy as a standardized procedurefor mediastinal lymph-node staging in non small cell carcinoma / M. Stefano [et al.] // Europ. J. Cardiothorac. Surg. - 2001. - Vol. 20.-P. 652-653.